Analyst Ratings for Progenics Pharmaceuticals (PGNX) [Buys]

PGNX Rating Summary

  |   Expand Research on PGNX
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 8 / 10   Percentile Rank: 82%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/30/2019 Brookline Capital Markets Kumaraguru Raja New Coverage Buy
(N/A)
10.00
(N/A)
5.18
(4.10)
-20.85% Details
12/7/2018 Credit Suisse N/A New Coverage Outperform
(N/A)
6.50
(N/A)
4.64
(4.10)
-11.64% Details
Like PGNX Ratings? Also take a look at

PGNX Ratings News